8-K: Alpha Cognition Announces Executive and Director Compensation Packages for 2025

Alpha Cognition Inc. unveils its 2025 compensation packages for executives and directors, aiming for the 50th percentile compared to a peer group of similar companies.

Summary

• On February 18, 2025, Alpha Cognition Inc. approved compensation packages for its CEO, COO, and Board members.
• The compensation packages include a combination of cash, stock options, and annual incentive awards.
• Michael McFadden, the CEO, will receive a $625,000 base salary, a $375,000 bonus target, and $2,500,000 in stock option compensation, totaling $3,500,000.
• Lauren D'Angelo, the COO, will receive a $500,000 base salary, a $300,000 bonus target, and $1,500,000 in stock option compensation, totaling $2,300,000.
• Director compensation includes a base salary of $40,000 ($70,000 for the Chairman), $95,000 in stock option grants, and additional compensation for committee leadership and membership.
• The Compensation Committee consulted with Global Governance Advisors (GGA) to benchmark compensation levels against a peer group of 14 companies.
• The goal is to compensate executives and directors at the 50th percentile of the peer group, with potential for higher compensation based on performance.

Sentiment

Score: 7

Explanation: The document is neutral to slightly positive. It outlines standard compensation practices and aims for market competitiveness, suggesting a stable and well-managed approach to executive and director compensation.

Positives

• The company is benchmarking executive and director compensation against a peer group to ensure competitiveness.
• The compensation packages include a mix of cash and equity, aligning executive and director interests with shareholders.
• The potential for higher compensation based on performance incentivizes executives to achieve superior results.
• The use of an independent compensation consultant (GGA) adds objectivity to the compensation-setting process.
• Long-standing non-employee directors received a one-time stock option grant as a catch-up bonus.

Future Outlook

The company aims to maintain competitive compensation levels for its executives and directors, aligning their interests with the company's performance and shareholder value.

Management Comments

• The Compensation Committee determined that the Company's CEO and COO should be compensated in the 50th percentile in accordance with the Peer Group, with the ability to achieve higher compensation in the case of superior performance.
• The Compensation Committee determined that the Company's Directors should be compensated in the 50th percentile.

Industry Context

In the biotech industry, it's common to benchmark executive and director compensation against peer companies, especially for pre-commercialization stage firms. This ensures the company can attract and retain talent while aligning compensation with performance and shareholder value.

Comparison to Industry Standards

• The document mentions that GGA conducted a review of a peer group of 14 companies to benchmark executive compensation levels.
• The goal is to position the CEO and COO's base salaries and long-term incentives around the 50th percentile of the peer group.
• This approach is consistent with industry best practices, where companies often target the median or slightly above-median compensation to attract and retain talent.
• Comparable companies in the biotech space, such as those in similar development stages and market capitalization ranges, often use similar benchmarking methodologies.
• For example, companies like Biohaven Pharmaceutical Holding Company Ltd. and Neurocrine Biosciences, Inc. also utilize peer group analysis to determine executive compensation.

Stakeholder Impact

• Shareholders: The compensation packages aim to align executive and director interests with shareholder value.
• Employees: Competitive compensation can improve employee morale and retention.
• Executives and Directors: The compensation packages directly impact their financial well-being.

Key Dates